Cargando…

Quantification of Lansoprazole in Oral Suspension by Ultra-High-Performance Liquid Chromatography Hybrid Ion-Trap Time-of-Flight Mass Spectrometry

An LC-MS/MS method was developed and validated to be used as a stability indicating assay for the study of a 3 mg/mL lansoprazole oral suspension. The method utilizes a UPLC (ultra-performance liquid chromatography) column and unique mass spectrometric detection (ion-trap time-of-flight (IT-TOF)) to...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Stacy D., Connor, Justin D., Smallwood, Nicholas C., Lugo, Ralph A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132987/
https://www.ncbi.nlm.nih.gov/pubmed/21754935
http://dx.doi.org/10.1155/2011/832414
_version_ 1782207890535219200
author Brown, Stacy D.
Connor, Justin D.
Smallwood, Nicholas C.
Lugo, Ralph A.
author_facet Brown, Stacy D.
Connor, Justin D.
Smallwood, Nicholas C.
Lugo, Ralph A.
author_sort Brown, Stacy D.
collection PubMed
description An LC-MS/MS method was developed and validated to be used as a stability indicating assay for the study of a 3 mg/mL lansoprazole oral suspension. The method utilizes a UPLC (ultra-performance liquid chromatography) column and unique mass spectrometric detection (ion-trap time-of-flight (IT-TOF)) to achieve a sensitive (LOD 2 ng/mL), accurate, and reproducible quantification of lansoprazole. This method reports an intraday and interday coefficient of variation of 2.98 ± 2.17% (n = 5 for each concentration for each day) and 3.07 ± 0.89% (n = 20 for each concentration), respectively. Calibration curves (5–25 μg/mL) were found to be linear with an R(2) value ranging from 0.9972 to 0.9991 on 4 different days. Accuracy of the assay, expressed as % error, ranged from 0.30 to 5.22%. This method is useful for monitoring the stability of lansoprazole in oral suspension.
format Online
Article
Text
id pubmed-3132987
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-31329872011-07-13 Quantification of Lansoprazole in Oral Suspension by Ultra-High-Performance Liquid Chromatography Hybrid Ion-Trap Time-of-Flight Mass Spectrometry Brown, Stacy D. Connor, Justin D. Smallwood, Nicholas C. Lugo, Ralph A. Int J Anal Chem Research Article An LC-MS/MS method was developed and validated to be used as a stability indicating assay for the study of a 3 mg/mL lansoprazole oral suspension. The method utilizes a UPLC (ultra-performance liquid chromatography) column and unique mass spectrometric detection (ion-trap time-of-flight (IT-TOF)) to achieve a sensitive (LOD 2 ng/mL), accurate, and reproducible quantification of lansoprazole. This method reports an intraday and interday coefficient of variation of 2.98 ± 2.17% (n = 5 for each concentration for each day) and 3.07 ± 0.89% (n = 20 for each concentration), respectively. Calibration curves (5–25 μg/mL) were found to be linear with an R(2) value ranging from 0.9972 to 0.9991 on 4 different days. Accuracy of the assay, expressed as % error, ranged from 0.30 to 5.22%. This method is useful for monitoring the stability of lansoprazole in oral suspension. Hindawi Publishing Corporation 2011 2011-06-22 /pmc/articles/PMC3132987/ /pubmed/21754935 http://dx.doi.org/10.1155/2011/832414 Text en Copyright © 2011 Stacy D. Brown et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Brown, Stacy D.
Connor, Justin D.
Smallwood, Nicholas C.
Lugo, Ralph A.
Quantification of Lansoprazole in Oral Suspension by Ultra-High-Performance Liquid Chromatography Hybrid Ion-Trap Time-of-Flight Mass Spectrometry
title Quantification of Lansoprazole in Oral Suspension by Ultra-High-Performance Liquid Chromatography Hybrid Ion-Trap Time-of-Flight Mass Spectrometry
title_full Quantification of Lansoprazole in Oral Suspension by Ultra-High-Performance Liquid Chromatography Hybrid Ion-Trap Time-of-Flight Mass Spectrometry
title_fullStr Quantification of Lansoprazole in Oral Suspension by Ultra-High-Performance Liquid Chromatography Hybrid Ion-Trap Time-of-Flight Mass Spectrometry
title_full_unstemmed Quantification of Lansoprazole in Oral Suspension by Ultra-High-Performance Liquid Chromatography Hybrid Ion-Trap Time-of-Flight Mass Spectrometry
title_short Quantification of Lansoprazole in Oral Suspension by Ultra-High-Performance Liquid Chromatography Hybrid Ion-Trap Time-of-Flight Mass Spectrometry
title_sort quantification of lansoprazole in oral suspension by ultra-high-performance liquid chromatography hybrid ion-trap time-of-flight mass spectrometry
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132987/
https://www.ncbi.nlm.nih.gov/pubmed/21754935
http://dx.doi.org/10.1155/2011/832414
work_keys_str_mv AT brownstacyd quantificationoflansoprazoleinoralsuspensionbyultrahighperformanceliquidchromatographyhybridiontraptimeofflightmassspectrometry
AT connorjustind quantificationoflansoprazoleinoralsuspensionbyultrahighperformanceliquidchromatographyhybridiontraptimeofflightmassspectrometry
AT smallwoodnicholasc quantificationoflansoprazoleinoralsuspensionbyultrahighperformanceliquidchromatographyhybridiontraptimeofflightmassspectrometry
AT lugoralpha quantificationoflansoprazoleinoralsuspensionbyultrahighperformanceliquidchromatographyhybridiontraptimeofflightmassspectrometry